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Abstract
Background: Although surgical ablation of atrial fibrillation is commonly performed during concomitant coronary
or valve surgery, it is still only performed in a fraction these cases when indicated, and less often in patients
undergoing aneurysm surgery. We describe our experience in patients undergoing ascending aneurysm repair and
concomitant atrial fibrillation ablation.
Methods: From January 2004 until November 2011, 40 patients underwent ascending aneurysm repair and atrial
fibrillation ablation at our institution and were retrospectively analyzed.
Results: Average age was 67.6 years (43–85). Root replacement was performed in 23 (57.5 %) and arch replacement
with circulatory arrest in 18 (45 %). At an average of 41.8 months, 81 % of patients were in sinus rhythm. Operative
survival was 100 %, with 1 and 5 year survival of 97.5 and 93.1 %, respectively. Kaplan-Meier analysis revealed
improved overall survival in patients with rhythm success (log-rank test p = 0.037).
Conclusions: Aortic aneurysm repair with concomitant atrial fibrillation ablation is safe and efficacious despite the
requirement for an already extensive procedure with rhythm success rates similar to those quoted in the setting of
other procedures. Successful restoration of sinus rhythm improves long term survival and should be considered in
patients presenting with aortic aneurysm and atrial fibrillation.
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Background
Atrial fibrillation (AF) is an independent risk factor for
stroke and death [1, 2]. It affects up to 1 % of the general
population, and 8 % of those over 80 [3]. With the rising
age of our society, the incidence of this disease is in-
creasing. Rate control strategies do not address the drop
in cardiac output or the risk of thromboembolism asso-
ciated with loss of atrial contraction, and the benefits as-
sociated with rhythm control are negated by the
significant side effects of the required medications [4].
The original “cut and sew” Cox-MAZE procedure
demonstrated 90–99 % long-term freedom from AF
[5, 6]. The development of energy modalities to create simi-
lar ablation lesions allowed for the simplification of the pro-
cedure. The modified Cox-MAZE III is now commonly
performed in patients with AF undergoing concomitant
cardiac surgery. Mitral valve repair/replacement (MVR) is
most commonly associated with surgical AF ablation as
these patients have frequently developed the substrate for
AF (i.e. left atrial dilation) and exposure is complimentary
[7]. Aortic valve replacement (AVR) and coronary artery
bypass grafting (CABG) are also well described in associ-
ation with surgical AF ablation [7]. Aneurysm surgery is
less commonly performed with surgical AF ablation, likely
due to the less common association of the two disease
states and the perception of an assumed increase in risk of
an already extensive procedure. We describe our experi-
ence in 40 patients undergoing ascending aneurysm repair
and concomitant surgical AF ablation with the goal of
demonstrating safety and efficacy.
Methods
Patient population
From January 2004 until November 2011, 40 patients
underwent ascending aneurysm repair and surgical AF
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ablation at our institution. Average age was 67.6 years
(43–85) and nine (23 %) patients were female. Concomi-
tant procedures were performed as indicated. Rhythm
was determined by electrocardiography. We defined the
type of AF in accordance with the Heart Rhythm
Society/European Heart Rhythm Association/European
Cardiac Arrhythmia Society Expert Consensus State-
ment [8]. Paroxysmal AF is defined as recurrent AF
(greater than two episodes) that terminates spontan-
eously within seven days. Persistent AF is defined as re-
current AF that is sustained for greater than 7 days.
Longstanding persistent AF is defined as continuous AF
of greater than one year’s duration. Permanent AF is de-
fined as AF whose presence is accepted by the patient
(and physician). This study was approved by the Weil
Cornell Medical College Institutional Review Board
(#1207012764).
Surgical approach
All cases were performed on cardiopulmonary bypass
with cold potassium cardioplegic arrest. Circulatory ar-
rest was utilized as needed for aortic arch reconstruc-
tions. Surgical AF ablation is generally performed first
after the heart has been arrested, after which mitral re-
pair/replacement is undertaken if indicated. Aortic valve
and aneurysm repair/replacement follow. If coronary by-
pass is indicated, distal anastomoses are performed prior
to AF ablation. If circulatory arrest is utilized, AF abla-
tion is generally performed first during the period of sys-
temic cooling.
For the left atrial lesion set, the left atrium is entered
via the interatrial groove. Five cryoablation lesions are
created for 60 s each at −120° centigrade. The right and
left pulmonary veins are isolated separately. A lesion
from the right pulmonary vein isolation to the P3 seg-
ment of the mitral annulus is created (mitral annulus le-
sion) as is a connecting lesion from the right to the left
pulmonary vein isolation. Finally, a lesion around the
base of the left atrial appendage is created which over-
laps the left pulmonary vein isolation.
For the right atrial lesion set, the right atrium is opened
via a vertical incision and caval lesions to the superior and
inferior vena cavae are created. Additional lesions
are created from atriotomy to the tricuspid annulus
at the anterior/septal commissure and the posterior/
septal commissure.
Demographics, risk factors, and outcomes
Preoperative variables examined included age, gender,
type of AF, duration of AF, left ventricular ejection frac-
tion, and left atrial size, as well as comorbidities. Intra-
operative variables included lesion sets performed,
operative times, and concomitant procedures. Postopera-
tive variables included postoperative complications such
as need for pacemaker placement, length of hospital
stay, rhythm success, and survival.
Statistical methods
Continuous variables are expressed as mean +/− stand-
ard deviation and categorical variables as frequency and
percentage. Continuous variables were compared with
the student’s t-test and categorical variables were com-
pared with the chi squared test or Fisher’s exact test as
appropriate. A p-value of less than 0.05 was considered
statistically significant. Kaplan-meier analysis was used
to calculate survival rates and the log-rank test was used
to determine statistical significance. Multivariable ana-
lysis was used to determine independent predictors of
rhythm success. All data were analyzed using STATA




From January 2004 until November 2011, 40 patients
underwent ascending aneurysm repair and surgical AF
ablation at our institution. Average age was 67.6 years
(43–85) and nine (23 %) patients were female. Pre-
operative comorbidities are listed in Table 1. Two patients
had Marfan syndrome. Twenty (53 %) patients had parox-
ysmal AF. The average duration of AF was 48.3 months.
Intraoperative details
Concomitant procedures are listed in Table 2. Two (5 %)
patients underwent reoperation. One had a prior type A
dissection repair 12 years prior and presented with
aneurysmal dilation of the aortic root and arch with aor-
tic insufficiency, and the other had a prior atrial septal
defect closure. One (2.5 %) patient had a prior
Table 1 Patient characteristics
n (%)*





Chronic renal insufficiency 1 (2.5)
Congestive heart failure 6 (15)
Cerebrovascular accident 5 (12.5)
Reoperative status 2 (5)
Paroxysmal atrial fibrillation 20 (53)
Preoperative left atrial size (centimeters) 4.4 (2.3–8.2)
Preoperative ejection fraction (%) 51.9 (29–80)
Duration of atrial fibrillation (months) 48.3 (1–324)
*-Unless otherwise stated
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thoracoabdominal aneurysm repair. Average cardiopul-
monary bypass time was 150.8 min and average cardiac
ischemic time was 118.4 min. Eighteen (45 %) patients
underwent arch or hemiarch reconstructions utilizing
circulatory arrest, with an average circulatory arrest time
of 21.1 min. All patients underwent a left atrial lesion
set, and four (10 %) patients underwent a right atrial le-
sion set at the surgeons’ discretion.
Postoperative outcomes
Average length of hospital stay was 7.4 days. One patient
had a preoperative pacemaker and five (12.8 %) patients
required pacemaker placement within the first 30 days
for heartblock or sick sinus syndrome. Three (7.5 %) pa-
tients required mediastinal reexploration for bleeding
and three (7.5 %) required drainage procedures for de-
layed pericardial effusions (one via pericardiocentesis,
one via pericardial window, and one via video assisted
thoracoscopic drainage).
Rhythm follow-up at one year or greater was available
in 90 % (35/39) of patients. Of these patients, at an aver-
age of 41.8 months, 81 % of patients were in sinus
rhythm, and 63 % were in sinus rhythm off antiarrhyth-
mic medications. In univariate analysis, predictors of
rhythm failure included congestive heart failure (0 vs
33 %; p = 0032), longer cardiopulmonary bypass time
(146.5 vs 180 min; p = 0.006), and longer crossclamp
time (112.2 vs 149.3 min; p = 0.005 [Table 3]). Longer
cardiopulmonary bypass and crossclamp times were
similarly predictive of rhythm failure despite use of anti-
arrhythmic medications. In multivariable logistic regres-
sion analysis, no specific factor was predictive of rhythm
failure.
Operative survival (survival to discharge and past
30 days) was 100 %. Overall survival was 90 % at an
average of 46 months (16–110 months), with actuarial
one and five year survivals of 97.5 and 93.1 %, respect-
ively. Kaplan-Meier analysis revealed improved overall
survival in patients with rhythm success (p = 0.037
[Fig. 1]).
Discussion
Although the initial Cox-MAZE procedures demon-
strated high rhythm success rates, their invasiveness pre-
cluded widespread application. With the development of
energy sources that can create the required lesion sets
with greater ease and minimal morbidity, surgical abla-
tion had become more frequently utilized, especially in
the setting of concomitant MVR [7]. The development
of novel techniques and minimally invasive approaches
has resulted in the application of surgical AF ablations
during off-pump procedures [9] or as a standalone proced-
ure [10]. However, up to 60 % of patients with AF undergo-
ing cardiac surgery do not undergo AF ablation [7]. This is
unfortunate as patients with preoperative AF undergoing
cardiac surgery have a worse prognosis than those without
AF [11–15], and AF ablation reverses this [14, 15].
Preoperative AF has been shown to correlate with op-
erative mortality after CABG [12], AVR/CABG, and AVR/
MVR [13] and midterm and longterm mortality after
Table 2 Associated procedures
n (%)
Aortic arch replacement: 18 (45)
Hemiarch 13
Total arch 5
Aortic root replacement: 23 (57.5)
Composite valve-graft 18
Valve sparing root replacement 5
Aortic valve procedure without root replacement: 9 (22.5)
Replacement 5
Repair 4
Mitral valve procedure: 9 (22.5)
Replacement 5
Repair 4
Tricuspid valve repair 1 (2.5)
Coronary artery bypass grafting 4 (10)
Atrial septal defect 1 (2.5)
Table 3 Univariate analysis
Normal Sinus Rhythm n (%)*
Yes No p-value
n = 25 n = 6
Female sex 5 (20) 0 (0) 0.553
Age (years) 65.2 67.2 0.669
Diabetes 2 (8) 1 (17) 0.488
Renal insufficiency 0 (0) 1 (17) 0.194
Hypertension 17 (68) 6 (100) 0.298
Hyperlipidemia 11 (44) 3 (50) 1.0
Cerebrovascular disease 3 (12) 2 (33) 0.241
Heart failure 0 (0) 2 (33) 0.032
Root repair 14 (56) 5 (83) 0.363
Arch repair 11 (44) 3 (50) 1.0
Aortic valve procedure 18 (72) 4 (67) 1.0
Mitral valve procedure 4 (16) 1 (17) 1.0
Persistent atrial fibrillation 9 (38) 3 (50) 0.660
Left atrial size (centimeters) 4.1 5.16 0.09
Ejection fraction (%) 52.4 47.7 0.281
Duration (months) 51.5 77 0.606
Bypass time (minutes) 146.5 180 0.006
Ischemia time (minutes) 112.2 149.3 0.005
*-Unless otherwise stated
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AVR, AVR/CABG, AVR/MVR [11, 13], and MVR [14]. As
expected, patients with preoperative AF presented with el-
evated comorbidity rates, but these relationships persisted
despite controlling for confounding factors [11–14]. In a
study of 281,567 patients from the Society of Thoracic
Surgeons National Adult Cardiac Surgery Database under-
going CABG by Ad et. al., preoperative AF was associated
with increased rates of reoperation, respiratory failure,
renal failure, stroke, increased length of stay, and mortality
despite adjustment for confounding factors. It was sug-
gested that AF be considered a risk factor in risk-
prediction models, as was recently done by the Society of
Thoracic Surgeons risk score [12].
Just as it has been well documented that preoperative
AF is a risk factor for poorer outcomes after cardiac sur-
gery, studies have demonstrated that this can be reversed
by successful AF ablation. Preoperative AF is an inde-
pendent predictor of longterm mortality after MVR [14].
Similarly, preoperative AF is associated with lower freedom
from thromboembolic complications [14] and surgical AF
ablation is protective [14, 16], lowering thromboembolic
event rates to those seen in patients without preoperative
AF [14]. These reductions in thromboembolic events after
AF ablation are seen despite continued anticoagulation for
mechanical valves [14, 16]. In a propensity matched analysis
of 3262 patients with AF and 2449 patients without AF
undergoing cardiac surgery, patients with preoperative AF
had reduced survival compared to patients with no
AF. AF ablation reversed this relationship, improving
survival rates to those seen in patients without AF.
Similarly, successfully ablated patients had better sur-
vival than unsuccessfully ablated patients [15]. In
addition to thromboembolism and mortality rates,
preoperative AF has been shown to correlate with
milder improvements in ejection fraction and greater
tricuspid regurgitation after MVR [14], and surgical
AF ablation results in greater improvement in ejec-
tion fraction [14, 16] and tricuspid regurgitation [16]
postoperatively.
Despite several such documented benefits of concomi-
tant surgical AF ablation during cardiac surgery, its less
than routine application in patients with preoperative
AF requires investigation. Amongst the potential expla-
nations are risks related to additional crossclamp and
bypass time, additional maneuvers for exposure, and in-
creased rates of postoperative bradyarrhythmias requir-
ing pacemaker implantation. Concomitant AF ablation
results in longer crossclamp (9 to 37 min longer) and
cardiopulmonary bypass (9 to 42 min longer) times
[7, 16] and increased pacemaker requirements [7, 17],
but even after controlling for confounders, surgical abla-
tion has been shown to be safe with no increased risk of
operative mortality or major morbidity [7]. Surgical abla-
tion has been routinely performed concomitant to valve/
CABG [7, 11, 13, 15], multiple valves [13, 14, 16], and reo-
perative [18] procedures with good outcomes. However,
no reports of aortic aneurysm surgery with surgical abla-
tion exist.
In the current study, aneurysm repair with concomi-
tant AF ablation was performed with 100 % operative
survival and greater than 90 % long term survival, with
no complications attributable to the ablation procedure.
Surgical ablation was performed in the setting of exten-
sive procedures with already prolonged cardiopulmonary
bypass and crossclamp times involving additional valve,
coronary, or arch surgery with circulatory arrest in a
high proportion of patients. Furthermore, survival was
improved in patients with successful ablation. This is the
Fig. 1 Kaplan-Meier Survival Curves for all patients based on rhythm success
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first study to our knowledge to demonstrate the safety
and efficacy of surgical AF ablation in patients undergo-
ing aortic aneurysm surgery. Prolonged cardiopulmonary
bypass time has been associated with increased blood
transfusion requirements, intensive care unit length of
stay [19], and mortality [20] after ascending aortic and
aortic arch repair. While we did not compare operative
times to a control group of patients undergoing aortic
aneurysm surgery without surgical AF ablation, all abla-
tions were performed via a left +/− right atriotomy
which in the majority of cases was not otherwise re-
quired for exposure for the given procedure. Thus it is
likely that operative times were significantly prolonged
for the ablation. Finally, rhythm success rates were simi-
lar to those published elsewhere despite a high percent-
age of patients with more persistent forms of AF.
Limitations of this study include those inherent to a
retrospective analysis using chart review and include in-
complete data, potential inaccuracies in data, and poten-
tial for selection bias. In addition, because of differences
in clinical practice across centers, extrapolation of re-
sults may be of limited value. Finally, the small sample
size, heterogeneity of surgical procedures, and lack of a
control group limit usefulness of statistical analyses.
Conclusions
In conclusion, aortic aneurysm repair with concomitant
surgical AF ablation is safe and efficacious despite the re-
quirement for an already extensive procedure. Excellent
short and long term survival can be achieved as can rhythm
success rates similar to those quoted in the setting of other
procedures. Successful restoration of sinus rhythm im-
proves long term survival and should be considered in pa-
tients presenting with aortic aneurysm and AF.
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